From Ovarian Cancer National Alliance:
Alliance Partner Members Nationwide to Sponsor “Teal Time” on Sept. 7 for Ovarian Cancer Awareness Month
Wearing the Color Teal Is Reminder That Ovarian Cancer Is the Deadliest of the Gynecologic Cancers; Knowing the Symptoms Can Save Lives
Each year, approximately 20,000 women are diagnosed with ovarian cancer and about 15,000 women die. The overall five-year relative survival rate for women with ovarian cancer is 45 percent. However, survival rate improves greatly – to 93 percent – if the cancer is diagnosed at an early stage, before it has spread. Currently, only 19 percent of ovarian cancer cases are diagnosed in this early stage.
Partner Member organizations of the Ovarian Cancer National Alliance want to change these statistics. To raise awareness of ovarian cancer and its symptoms, these organizations will sponsor “Teal Time” on Friday, September 7. Alliance Partner Members across the United States will wear the color teal and encourage others to do so as a focal point during Ovarian Cancer Awareness Month activities.
Partner Members – local and state ovarian cancer groups – will spread the message about wearing teal to ovarian cancer patients, survivors, advocates, caregivers, family, friends, co-workers and others who want to raise awareness about this disease.
Teal is the ovarian cancer community’s color – like pink is for breast cancer – and a reminder that ovarian cancer is the deadliest of all the cancers of the reproductive system and a leading cause of cancer death among women.
The idea for “Teal Time” was conceived by Alliance co-founder Bonnie Donihi, executive director of the Ovarian Cancer Alliance of Florida in Orlando. “It’s time to get loud about a disease that will again take 15,000 women’s lives this year,” Ms. Donihi said.
Ovarian cancer’s symptoms are subtle, difficult to diagnose and often misdiagnosed. Contrary to popular opinion, a Pap smear does NOT test for ovarian cancer – it is a screening for cervical cancer. Because there is not a reliable screening test, less than one in five women will be diagnosed in the early stages of ovarian cancer. However, with early diagnosis, more than nine out of 10 women will survive for more than five years.
Many people mistakenly believe that there are no symptoms. However, published research has proven that at least 80 percent of women with early-stage ovarian cancer have symptoms for several months prior to diagnosis. While certain factors – including a personal or family history of ovarian, breast or colorectal cancer – can increase a woman’s risk, every woman is susceptible to the disease.
The following symptoms are much more likely to occur in women with ovarian cancer than women in the general population. These symptoms include:
Bloating
Pelvic or abdominal pain
Difficulty eating or feeling full quickly
Urinary symptoms (urgency or frequency)
Women with ovarian cancer report that symptoms are persistent and represent a change from normal for their bodies. The frequency and/or number of such symptoms are key factors in the diagnosis of ovarian cancer. Several studies show that even early-stage ovarian cancer can produce these symptoms.
Women who have these symptoms almost daily for more than a few weeks should see their doctor, preferably a gynecologist. Prompt medical evaluation may lead to detection at the earliest possible stage of the disease. Early-stage diagnosis is associated with an improved prognosis.
The Ovarian Cancer National Alliance, the nation’s voice for ovarian cancer issues, is a survivor-led umbrella organization uniting activists, women’s health advocates and health care professionals in the effort to increase public and professional understanding of ovarian cancer and to advocate for more effective diagnostics, treatments and a cure.